Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events

NCT00886574 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Cilostazol
DRUG: Aspirin

Sponsor

Hanyang University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]